News and History
-
Confusion surrounds CDC’s ‘shared clinical decision-making’ paradigm for childhood vaccines
Read More: Confusion surrounds CDC’s ‘shared clinical decision-making’ paradigm for childhood vaccinesOn Jan. 6, 2025, the Centers for Disease Control and Prevention (CDC) said “shared clinical decision-making” would be
-
West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule
Read More: West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine ScheduleOn Jan. 5, 2026, the Acting Director of the Centers for Disease Control and Prevention signed a decision
-
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
Read More: Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across AmericaOn Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help
-
Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemic
Read More: Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemicOn Jan. 5, 2026, U.S. flu infections surged over the holidays, and health officials are calling it a
-
CMS to stop requiring states to report childhood vaccination levels
Read More: CMS to stop requiring states to report childhood vaccination levels -
Welder’s Anthrax Treated with Obiltoxaximab in Louisiana, fatalities Reported
Read More: Welder’s Anthrax Treated with Obiltoxaximab in Louisiana, fatalities ReportedOn Jan. 1, 2026, the Centers for Disease Control and Prevention (CDC) reported that in September 2024, the
-
US measles outbreak tops 2,000 known infections
Read More: US measles outbreak tops 2,000 known infectionsOn Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)
-
WHO reported Middle East respiratory syndrome coronavirus outbreak continues
Read More: WHO reported Middle East respiratory syndrome coronavirus outbreak continuesOn Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as
-
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
Read More: FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adultsOn Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved
-
Scientists Map the Human Genome in 4D
Read More: Scientists Map the Human Genome in 4DOn Dec. 22, 2025, scientists at Northwestern University announced a landmark effort to understand how the physical structure
-
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
Read More: Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSKOn Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Read More: FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic CardiomyopathyOn Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),
-
A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic review
Read More: A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic reviewOn Dec. 20, 2025, a new study published in the journal BMC Infectious Diseases reported that viral emergence
-
Novartis and U.S. government reach agreement on lowering drug prices
Read More: Novartis and U.S. government reach agreement on lowering drug pricesOn Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
Read More: BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare DiseasesOn Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement
-
CRISPR primes goldenberry for fruit bowl fame
Read More: CRISPR primes goldenberry for fruit bowl fameOn Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this
-
WHO validates Brazil for eliminating mother-to-child transmission of HIV
Read More: WHO validates Brazil for eliminating mother-to-child transmission of HIVOn Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of
-
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
Read More: Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 YearsOn Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease
-
Space Station Research Supports New FDA-Approved Cancer Therapy
Read More: Space Station Research Supports New FDA-Approved Cancer TherapyOn Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space
-
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
Read More: Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
